Implantable Infusion Pumps Global Market To Reach Value Of About $19 Billion In 2025

1 Dec, 2021

Check out TBRC’s sale today for

The implantable infusion pumps market consists of sales of implantable infusion pumps and related services by entities (organizations, sole traders and partnerships) that manufacture implantable infusion pumps. An implantable infusion pump is a small device that is put beneath the skin during the operation. The pump delivers the liquid pain medication to a different part of the body through a long, flexible tube called the catheter.

Global Implantable Infusion Pumps Market Size And Drivers:

The global implantable infusion pumps market is expected to decline from $16.21 billion in 2020 to $15.15 billion in 2021 at a compound annual growth rate (CAGR) of -6.6%. The decline in the market is mainly due to the companies decreasing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The implantable infusion pumps market is expected to reach $19.03 billion in 2025 at a CAGR of 6%. The increased prevalence of people with chronic pain, cancer and diabetes is expected to drive the demand for implantable infusion pumps, as these pumps are commonly used to deliver pharmaceutical drugs during the treatment of these diseases.

Request For A Sample For The Global Implantable Infusion Pumps Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3347&type=smp

Trends In The Global Implantable Infusion Pumps Market

Companies in the implantable infusion pump market are increasingly focusing on developing smart infusion pumps. The use of wireless technology in the health monitoring devices is increasing, which enhances the ease of usage, connectivity and data analysis. The integration of wireless technology allows the transfer of data from the device to a smartphone or a wireless device through Bluetooth or cellular connection for data processing and then to display the results, which can be used for further study and to check the health condition of the individual. Software platforms are being developed that allow patient monitoring and reduce human error. In June 2019, Ivenix, a US-based medical device company, received clearance for a new smart infusion pump, which reduces human and software error with more streamlined technology.

Global Implantable Infusion Pumps Market Segments:
The global implantable infusion pumps market is further segmented –
By Type: Patient-Controlled Analgesia (PCA) Pumps, Enteral Pumps, Insulin Pumps, Elastomeric Pumps, Syringe Pumps, Others
By Applications: Oncology, Pediatrics/Neonatology, Gastroenterology, Hematology, Diabetes, Others
By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics
By Geography: The global implantable infusion pumps market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global Implantable Infusion Pumps Market At:

https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report-2020-30-covid-19-growth-and-change

Implantable Infusion Pumps Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides implantable infusion pumps market overviews, analyzes and forecasts market size and growth for the global implantable infusion pumps market, implantable infusion pumps market share, implantable infusion pumps market players, implantable infusion pumps market segments and geographies, implantable infusion pumps market’s leading competitors’ revenues, profiles and market shares. The implantable infusion pumps market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.